September 2025 – content
Life Sciences
Illumina to buy SomaLogic after 18 months as part of Standard BioTools
Serva Electrophoresis joins LICOR bio
Nicoya adds to SPR offering with circular dichroism spectrometer veteran
Antibodies.com moves to new HQs
Bruker expands MS reach in metabolomics and microbiology
Bankrupt Synthego bought by US equity company
Twist spins out data storage assets with help of investors
Imagene AI raises funds
General Laboratory
Two more acquisitions continue SDI’s inorganic growth strategy
Köttermann owner changes equity-investment hands
Zeiss starts new microoptics segment
AnalytiChem rebrands latest acquisition Cherwell
Zeiss buys SPAD pioneer to advance microscopy sensitivity
MKS Instruments renames
Process & hand-held instrumentation
Acquisition highlights Sensirion’s emission monitoring strategy
Veralto invests into equity company’s water fund
Wabtec completes purchase of Evident NDT business
Substantial licensing deal to change Kromek’s fortunes for next two years
Emerson reverses segment divestment decision citing re-shoring trends
LK Metrology expands offering with two acquisitions
Financials
Record-breaking Twist Bio confirms full-year guidance
Bio-Rad LS grows on process chromatography
LS to grow at low single digits in Danaher’s second calendar half
Weak Illumina spared worse by sequencing consumables success
Dassault LS sees signs of recovery
Analytics grows by 2% during Xylem's first half
Currencies responsible for Nikon HC’s single digit growth
Agilent back to growth in its new configuration
Organic growth for SDI in second half of fiscal year
Analytical Instruments weak at Thermo Fisher
Zeiss’ microscopy and NDT segment declines slightly
Köttermann continues growth at lower rates
Emerson MA business flatlines organically in the second quarter
Kromek halves sales and double losses on eve of turnaround deal
Nederman MCT faces weak markets in first half
Water quality ahead of product quality by growth at Veralto
Valmet Automation relies on purchase for growth
Solventum PF leads by organic growth in the first half
Appointments
